• search

Morepen Laboratories restructuring package admitted in CDR

By Staff
Subscribe to Oneindia News

Mumbai, May 05 (UNI) Morepen Laboratories Ltd today announced that its Corporate Debt Restructuring (CDR) proposal of Rs 7,500 million has been formally admitted for consideration by the Empowered Group of the CDR.

Informing the BSE, the company said the restructuring proposal envisages one time settlement (OTS) with majority of lenders after induction of fresh capital by the strategic investors.

The fresh money will come by a combination of Debt and Equity/FCCB.

The restructuring proposal also provides one time settlement with FD holders subject to necessary approvals and the funding of equisite working capital and capital expenditure required by the company.

The company is expected to complete the above process in the course of next 3-4 months and regain its market share.

During the fiscal year 2005-06, the company has consolidated its business activities and has recorded a growth of 34 per cent in gross revenues amounting to Rs 133.61 crore.

The exports forming 62 per cent of the total sales have grown by 34 per cent. Similarly formulations, contract manufacturing, diagnostics and Doctor Morepen's range of products have also registered handsome growth.

The EBIDTA(earnings before interest depreciation tax allowance) margins have increased from 3 to 13 per cent on account of various cost cutting measures adopted by the company, which is expecting a robust growth in its revenues during the financial year 2006-2007.

UNI SN PP VKG1719

For Breaking News from Oneindia
Get instant news updates throughout the day.

X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more